SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Last Play is Crypto’s 401k.  RETIRE is more than a coin; it’s The Last Play. We are a community dedicated to breaking free from the grind and building true generational wealth. With RETIRE, our mission is simple yet profound: to provide a pathway to retire yourself and secure financial freedom for your bloodline. While others chase hype and trends, we’re focused on creating a legacy that lasts beyond the typical cycle. RETIRE is about making the one move that matters, with a vision for long-term value, freedom, and impact. This isn’t just a meme —it’s a purpose-driven commitment to building a legacy.

The Last Play

RETIRE is trending as a "tokenized 401(k)" movement, with the community actively rallying around its mission to challenge traditional retirement systems and secure generational wealth. Supporters are driving engagement through weekly "DCA Friday" purchases, positioning it as a relatable long-term alternative to traditional finance.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors debate its potential for long-term growth and brand expansion, with community members closely tracking recent price movements alongside broader market volatility. Many are discussing the project's IP-driven model as a differentiator while speculating on its ability to sustain a rally during current crypto market conditions.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as investors and social media users heatedly debate the company's future amid volatility, recent trade-related news, and ongoing political controversy. The community remains deeply polarized, with active discussions focused on the stock's valuation, leadership, and the broader implications of trade and economic policies.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

Immix Biopharma is trending as investors digest the company's recent capital raise and updated trial data, with community members debating the strategic decision to dilute shares while highlighting the asset's clinical potential. Discussions remain focused on the firm's NXC-201 therapy, institutional accumulation, and the potential for a larger strategic acquisition within the biotech space.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereum is drawing significant attention as community members discuss its potential to outperform Bitcoin through institutional adoption, network activity, and the proliferation of ecosystem applications. The focus has intensified amid active debates over the role of institutional flows versus market structure and the influence of prominent industry voices.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

Community members are actively debating whether the token is a pump-and-dump scheme, with many users expressing frustration over significant losses and questioning its lack of utility. The conversation is largely dominated by skepticism and criticism regarding the association with the Trump family and its dramatic decline in value from earlier peaks.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently trending as shareholders and analysts react to a recent Medicare coverage expansion for immunotherapy monitoring, though investor sentiment remains conflicted due to a contentious all-stock acquisition agreement with Tempus AI. The community is actively debating the deal's valuation and the potential for a superior competing bid given the stock's strategic importance to the oncology sequencing market.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential impact of pending regulatory clarity on its payment utility and long-term viability, with many community members engaging in heated discussions about recent management changes and historical price performance. Discussions focus on whether the project's infrastructure foundation justifies current accumulation strategies or if the asset remains a speculative trap.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound is trending as community members discuss a potential supply shock due to the token's limited supply, while debating whether current price action reflects institutional accumulation or continued market manipulation.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending as investors monitor institutional accumulation, technical support near yearly lows, and ongoing community speculation regarding a potential acquisition of Celsius Holdings. Traders are closely tracking the stock's dividend stability and the impact of broader rotation into defensive staples as they weigh the potential for a rebound toward higher resistance levels.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) PR Newswire NEW YORK, July 21, 2026 NEW...

Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5%

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,465,993 shares, an increase of 8,397.5% from the March 31st total of 17,252 shares. Based on an average...

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Sees Large Decrease in Short Interest

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large decrease in short interest in March. As of March 31st, there was short interest totaling 17,252 shares, a decrease of 30.6% from the March 15th total of 24,866 shares. Based on an average daily volume of 43,602...

JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA

JPMorgan Chase & Co. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the...

Drugs Made In America Acquisition (NASDAQ:DMAA)  Shares Down 0%   - What's Next?

Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0% - Here's Why...

Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA

Clear Street Group Inc. bought a new stake in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the...

Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA

Radcliffe Capital Management L.P. increased its stake in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) by 316.7% during the 3rd quarter, according to its most recent...

Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA

Context Capital Management LLC purchased a new position in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) during the third quarter, according to the company in its most recent...

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Short Interest Down 21.7% in February

Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Get Free Report) saw a large drop in short interest in February. As of February 13th, there was short interest totaling 28,441 shares, a drop of...

Drugs Made In America Acquisition (NASDAQ:DMAA) Stock Price Up 0.1% - Here's Why

Drugs Made In America Acquisition (NASDAQ:DMAA) Trading 0.1% Higher - Still a Buy...

Drugs Made In America Acquisition Corp. is a blank check company, which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The company was founded on May 23, 2024 and is headquartered in New York, NY.

Drugs Made In America Acquisition Corp.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$10.75
Prev Close	$10.73
Open	$10.73
Dividend Yield	0.00%
50-Day Moving Average	$10.68
Beta	-0.11
Avg. Volume	39,696.18
PE Ratio	57.80

52-Week High	$10.75
52-Week Low	$10.22
Market Capitalization	$260.98M
EPS (Annual)	$0.1762
Price to Book	1.89
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info